# Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer

> **NCT00842582** · PHASE1 · WITHDRAWN · sponsor: **Loyola University**

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Azacitidine
- **DRUG:** Azacitidine
- **DRUG:** Azacitidine

## Key facts

- **NCT ID:** NCT00842582
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-02
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No enrollment. Unable to recruit due to lack of eligible patients.
- **Last updated:** 2016-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842582, "Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT00842582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*